ZA200701570B - Novel polymorphs of azabicyclohexane - Google Patents
Novel polymorphs of azabicyclohexaneInfo
- Publication number
- ZA200701570B ZA200701570B ZA200701570A ZA200701570A ZA200701570B ZA 200701570 B ZA200701570 B ZA 200701570B ZA 200701570 A ZA200701570 A ZA 200701570A ZA 200701570 A ZA200701570 A ZA 200701570A ZA 200701570 B ZA200701570 B ZA 200701570B
- Authority
- ZA
- South Africa
- Prior art keywords
- azabicyclohexane
- novel polymorphs
- polymorphs
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92074804A | 2004-08-18 | 2004-08-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200701570B true ZA200701570B (en) | 2008-08-27 |
Family
ID=35968183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200701570A ZA200701570B (en) | 2004-08-18 | 2005-08-17 | Novel polymorphs of azabicyclohexane |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1786417A4 (ja) |
JP (1) | JP2008510715A (ja) |
KR (3) | KR20130108489A (ja) |
CN (1) | CN101052393A (ja) |
AU (1) | AU2005277351A1 (ja) |
BR (1) | BRPI0515193A (ja) |
CA (1) | CA2619817A1 (ja) |
IL (1) | IL181185A (ja) |
MX (1) | MX2007001827A (ja) |
NO (1) | NO20071372L (ja) |
NZ (1) | NZ589033A (ja) |
RU (1) | RU2007109817A (ja) |
WO (1) | WO2006023659A2 (ja) |
ZA (1) | ZA200701570B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
BRPI0613943B1 (pt) | 2005-07-27 | 2021-06-22 | Otsuka America Pharmaceutical, Inc | Composto, composição farmacêutica o compreendendo, usos de um composto e de uma composição farmacêutica, bem como composição neurobiologicamente ativa |
US20080045725A1 (en) * | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
US8138377B2 (en) | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
JP2013544850A (ja) * | 2010-12-03 | 2013-12-19 | ユーシミクス バイオサイエンス,インク. | モノアミン神経伝達物質によって影響を受ける病態の処置における(+)−1−(3,4−ジクロロフェニル)−3−アザビシクロ[3.1.0]ヘキサンの調製および使用 |
US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
EP2994129A4 (en) * | 2013-05-07 | 2017-01-25 | Euthymic Bioscience, Inc. | Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders |
KR101567003B1 (ko) | 2013-12-27 | 2015-11-06 | 경희대학교 산학협력단 | 골편 고정장치 및 골편 절단을 위한 드릴 어셈블리 |
CA2989431C (en) | 2015-06-17 | 2023-08-29 | Franklin Bymaster | Crystalline compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
-
2005
- 2005-08-17 KR KR1020137024105A patent/KR20130108489A/ko not_active Application Discontinuation
- 2005-08-17 KR KR1020127030289A patent/KR20130004370A/ko not_active Application Discontinuation
- 2005-08-17 CN CNA2005800279269A patent/CN101052393A/zh active Pending
- 2005-08-17 KR KR1020077006293A patent/KR20070054208A/ko not_active Application Discontinuation
- 2005-08-17 RU RU2007109817/04A patent/RU2007109817A/ru not_active Application Discontinuation
- 2005-08-17 NZ NZ589033A patent/NZ589033A/en not_active IP Right Cessation
- 2005-08-17 ZA ZA200701570A patent/ZA200701570B/xx unknown
- 2005-08-17 JP JP2007528015A patent/JP2008510715A/ja active Pending
- 2005-08-17 WO PCT/US2005/029420 patent/WO2006023659A2/en active Application Filing
- 2005-08-17 MX MX2007001827A patent/MX2007001827A/es active IP Right Grant
- 2005-08-17 AU AU2005277351A patent/AU2005277351A1/en not_active Abandoned
- 2005-08-17 CA CA002619817A patent/CA2619817A1/en not_active Abandoned
- 2005-08-17 BR BRPI0515193-7A patent/BRPI0515193A/pt not_active IP Right Cessation
- 2005-08-17 EP EP05785506A patent/EP1786417A4/en not_active Withdrawn
-
2007
- 2007-02-06 IL IL181185A patent/IL181185A/en not_active IP Right Cessation
- 2007-03-14 NO NO20071372A patent/NO20071372L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101052393A (zh) | 2007-10-10 |
NZ589033A (en) | 2012-06-29 |
JP2008510715A (ja) | 2008-04-10 |
IL181185A (en) | 2012-10-31 |
WO2006023659A3 (en) | 2006-12-07 |
AU2005277351A1 (en) | 2006-03-02 |
EP1786417A4 (en) | 2009-05-20 |
KR20130108489A (ko) | 2013-10-02 |
WO2006023659A2 (en) | 2006-03-02 |
RU2007109817A (ru) | 2008-09-27 |
CA2619817A1 (en) | 2006-03-02 |
NO20071372L (no) | 2007-05-18 |
MX2007001827A (es) | 2007-04-23 |
KR20130004370A (ko) | 2013-01-09 |
EP1786417A2 (en) | 2007-05-23 |
IL181185A0 (en) | 2007-07-04 |
KR20070054208A (ko) | 2007-05-28 |
BRPI0515193A (pt) | 2008-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1778618E (pt) | Síntese de trietilenotetraminas | |
IL181587A0 (en) | Production of ??-abeta | |
PL1802579T3 (pl) | Pochodne 3-aryloaminopirydynowe | |
IL182580A0 (en) | Polymorphic forms of 6-[2- | |
GB0400812D0 (en) | Novel compounds | |
EP1718638A4 (en) | NEW COMPOUNDS | |
IL181185A0 (en) | Novel polymorphs of azabicyclohexane | |
EP1711484A4 (en) | SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES | |
EP1804582A4 (en) | POLYMORPH SHAPES OF TADALAFIL | |
GB0402140D0 (en) | Novel compounds | |
IL185029A0 (en) | Preparation of tadalafil intermediates | |
GB0402496D0 (en) | Novel compounds | |
GB0402357D0 (en) | Novel compounds | |
EP1805132A4 (en) | NEW COMPOUNDS | |
EP1796793A4 (en) | NEW CONNECTIONS | |
IL181164A0 (en) | Novel uses of 2-phenyl-substituted imidazotriazinone derivatives | |
SI1812422T1 (sl) | Kristalna oblika irbesartana | |
ZA200703630B (en) | Polymorphs of sarsapogenin | |
GB0402812D0 (en) | Novel compounds | |
GB0402355D0 (en) | Novel compounds | |
IL178184A0 (en) | Synthesis of pyrrole-2-carbonitriles | |
GB0402356D0 (en) | Novel compounds | |
GB0402380D0 (en) | Novel compounds | |
SI1709057T1 (sl) | Sinteza spongozina | |
ZA200508325B (en) | Manufacture of kerbstones |